Plett Helmut, Ricciardi Enzo, Harter Philipp, Ataseven Beyhan, Heitz Florian, Prader Sonia, Schneider Stephanie, Heikaus Sebastian, Fisseler-Eckhoff Annette, Kommoss Friedrich, Lax Sigurd F, Staebler Annette, Traut Alexander, du Bois Andreas
Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
Department of Gynecology, Charité University Hospital, Berlin, Germany.
Data Brief. 2020 Apr 30;30:105653. doi: 10.1016/j.dib.2020.105653. eCollection 2020 Jun.
The data presented here is related to the research article entitled "FERTILITY-SPARING SURGERY AND REPRODUCTIVE-OUTCOMES IN PATIENTS WITH BORDERLINE OVARIAN TUMORS" by Plett et al. in Journal of Gynecologic Oncology [1] and is analysed and discussed in detail. 18 Patients with Recurrent Borderline Ovarian Tumors (BOT) were identified and listed in Table 1. All patients underwent treatment for primary BOT either per radical surgery (RS) or fertility sparing surgery (FSS) by the same team in Horst Schmidt Klinik (HSK) in Wiesbaden and the Department of Gynecology and Gynecologic Oncology at Kliniken Essen-Mitte between January 2000 and December 2018 and were followed up closely. Details on patients` and surgical characteristics are given as well as management of character of recurrent disease. In Table 2 important publications from the last 20 years are listed in order to visualize better the oncologic outcomes (invasive and non-invasive relapses) and calculated risks of recurrence with the purpose to understand better the important findings of the related article cited above.
此处呈现的数据与Plett等人发表在《妇科肿瘤学杂志》[1]上的题为“卵巢交界性肿瘤患者的保留生育功能手术与生殖结局”的研究文章相关，并进行了详细的分析和讨论。确定了18例复发性卵巢交界性肿瘤（BOT）患者，并列入表1。2000年1月至2018年12月期间，所有患者均由威斯巴登的霍斯特·施密特诊所（HSK）以及埃森-米特诊所的妇科和妇科肿瘤学部门的同一团队，接受了针对原发性BOT的根治性手术（RS）或保留生育功能手术（FSS）治疗，并进行了密切随访。给出了患者和手术特征的详细信息以及复发性疾病特征的处理方法。表2列出了过去20年的重要出版物，以便更好地直观呈现肿瘤学结局（侵袭性和非侵袭性复发）以及计算出的复发风险，目的是更好地理解上述相关文章的重要发现。
